Proceed with caution: Peginterferon alpha‐2a versus peginterferon alfa‐2b in chronic hepatitis C. A systematic review of randomized trials
David Kershenobich, Linda Muñoz, René Malé, Jesús Gaytan, Francisco Sánchez – 6 October 2010
Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection
Jennifer R. Kramer, Christine Y. Hachem, Fasiha Kanwal, Minghua Mei, Hashem B. El‐Serag – 6 October 2010 – Coinfection with hepatitis A virus (HAV) or hepatitis B virus (HBV) in patients with chronic hepatitis C virus (HCV) is associated with increased morbidity and mortality. The Center for Medicare and Medicaid Services has identified HAV and HBV vaccination as a priority area for quality measurement in HCV. It is unclear to what extent patients with HCV meet these recommendations.
Working with a gold‐plated standard
Terry Therneau – 6 October 2010
Necrosis versus apoptosis in acetaminophen‐induced hepatotoxicity
Klaus Schulze‐ Osthoff, Heike Bantel – 6 October 2010
CXC chemokine receptor‐1 is expressed by hepatocytes and regulates liver recovery after hepatic ischemia/reperfusion injury
Callisia Clarke, Satoshi Kuboki, Nozomu Sakai, Kevin R. Kasten, Amit D. Tevar, Rebecca Schuster, John Blanchard, Charles C. Caldwell, Michael J. Edwards, Alex B. Lentsch – 6 October 2010 – CXC chemokines mediate hepatic inflammation and injury following ischemia/reperfusion (I/R). More recently, signaling through CXC chemokine receptor‐2 (CXCR2) was shown to delay liver recovery and repair after I/R injury. The chemokine receptor CXCR1 shares ligands with CXCR2, yet nothing is known about its potential role in liver pathology.
Effects of the infant stool color card screening program on 5‐year outcome of biliary atresia in taiwan
Tien‐Hau Lien, Mei‐Hwei Chang, Jia‐Feng Wu, Huey‐Ling Chen, Hung‐Chang Lee, An‐Chyi Chen, Mao‐Meng Tiao, Tzee‐Chung Wu, Yao‐Jong Yang, Chieh‐Chung Lin, Ming‐Wei Lai, Hong‐Yuan Hsu, Yen‐Hsuan Ni, the Taiwan Infant Stool Color Card Study Group – 6 October 2010 – In Taiwan, a screening system using an infant stool color card to promote the early diagnosis of biliary atresia (BA) was established in 2002. This study aimed to investigate the 5‐year outcome of BA before and after using the screening program. BA patients were divided into three cohorts according to their birth dates.
Erratum: Patatin‐like phospholipase domain‐containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease
Weiqin Chen, Benny Chang, Lan Li, Lawrence Chan – 5 October 2010
Drug‐induced postinfantile giant cell hepatitis
Ricardo Moreno‐Otero, María Trapero‐Marugán, Luisa García‐Buey, Asunción García‐Sancchez – 1 October 2010
p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3‐kinase/AKT/hypoxia‐inducible factor‐1α pathways
Jing Fu, Yao Chen, Jie Cao, Tao Luo, You‐Wen Qian, Wen Yang, Yi‐Bin Ren, Bo Su, Guang‐Wen Cao, Yuan Yang, Yi‐Qun Yan, Feng Shen, Meng‐Chao Wu, Gen‐Sheng Feng, Hong‐Yang Wang – 30 September 2010 – The overall survival of patients with hepatocellular carcinoma (HCC) remains poor, and the molecular mechanisms underlying HCC progression and aggressiveness are unclear. Here, we report that increased expression of p28GANK (Gankyrin, PSMD10, or p28) in human HCC predicts poor survival and disease recurrence after surgery.